[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 205
Citations 0
Comment & Response
March 2014

Caution Warranted When Defining Contraindications in Initiating β-Blocker Therapy

Author Affiliations
  • 1Department of Pharmacy, Jackson Memorial Hospital, Miami, Florida
JAMA Intern Med. 2014;174(3):481. doi:10.1001/jamainternmed.2013.13698

To the Editor Dharmarajan and colleagues1 are to be commended for their review of hospitalized patients with acute decompensated heart failure initiated on β-blocker therapy during predefined periods of clinical instability, which showed that at least 40% of those initiated had at least 1 possible contraindication (care in an intensive care unit, administration of intravenous loop diuretic on the day of discharge, or having received an intravenous inotrope during hospitalization).

First Page Preview View Large
First page PDF preview
First page PDF preview